Literature DB >> 14998587

Characterization of jejunal absorption and apical efflux of ropivacaine, lidocaine and bupivacaine in the rat using in situ and in vitro absorption models.

Sofia Berggren1, Janet Hoogstraate, Urban Fagerholm, Hans Lennernäs.   

Abstract

The purpose of this study was to characterize the rat jejunal passive transport and the possible active efflux of three local anaesthetics, ropivacaine, lidocaine and bupivacaine using two different absorption models, the in situ single-pass intestinal perfusion and the in vitro Ussing chamber model, as well as P-glycoprotein (Pgp)-mediated calcein transport inhibition in Caco-2 cells. Concentration and pH dependence, efflux inhibition by verapamil and digoxin and bi-directional permeability studies were performed to investigate the potential involvement of efflux carriers in the intestinal absorption of the local anaesthetics. In the jejunal perfusion the permeability of these agents appeared to be high, predicting complete intestinal absorption (>90%). There was no effect of the Pgp inhibitors on net absorption for any of the local anaesthetics in the two absorption models. However, in the Ussing chamber at an equal pH of 7.4 at mucosal and serosal sides, the observed jejunal permeability ratios (S-M)/(M-S), of 2.3, 1.8 and 3.0 for ropivacaine, lidocaine and bupivacaine, respectively, indicated at least some involvement of carrier-mediated intestinal secretion. This idea was supported in the calcein AM Pgp transport assay in which two of the tested local anaesthetic agents affected cellular calcein retention. As anticipated for these agents, the mucosal pH conditions were shown to largely affect the gut permeability. The jejunal permeabilities of the local anaesthetics as measured in the two absorption models fitted well in a model comparison that incorporated the permeabilities of six other structurally unrelated drugs. In conclusion, the jejunal permeability of ropivacaine, lidocaine and bupivacaine was high and although evidence was obtained for carrier-mediated intestinal efflux this process appeared not to have a significant influence on the rate and extent of in vivo intestinal absorption. Rather, passive diffusion of these agents seems to be the major mechanism for the intestinal absorption.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14998587     DOI: 10.1016/j.ejps.2003.12.004

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  7 in total

Review 1.  Application of method suitability for drug permeability classification.

Authors:  Donna A Volpe
Journal:  AAPS J       Date:  2010-09-02       Impact factor: 4.009

2.  Intestinal absorption of novel-dipeptide prodrugs of saquinavir in rats.

Authors:  Ritesh Jain; Sridhar Duvvuri; Viral Kansara; Nanda Kishore Mandava; Ashim K Mitra
Journal:  Int J Pharm       Date:  2006-12-03       Impact factor: 5.875

3.  Effect of experimental temperature on the permeation of model diffusants across porcine buccal mucosa.

Authors:  Upendra Dilip Kulkarni; Ravichandran Mahalingam; Xiaoling Li; Indiran Pather; Bhaskara Jasti
Journal:  AAPS PharmSciTech       Date:  2011-05-04       Impact factor: 3.246

4.  Cell-based assays using calcein acetoxymethyl ester show variation in fluorescence with treatment conditions.

Authors:  Fayth L Miles; Jill E Lynch; Robert A Sikes
Journal:  J Biol Methods       Date:  2015

5.  The H2 receptor antagonist nizatidine is a P-glycoprotein substrate: characterization of its intestinal epithelial cell efflux transport.

Authors:  Arik Dahan; Hairat Sabit; Gordon L Amidon
Journal:  AAPS J       Date:  2009-03-25       Impact factor: 4.009

6.  3D Lung-on-Chip Model Based on Biomimetically Microcurved Culture Membranes.

Authors:  Danielle Baptista; Liliana Moreira Teixeira; David Barata; Zeinab Tahmasebi Birgani; Jasia King; Sander van Riet; Thijs Pasman; André A Poot; Dimitrios Stamatialis; Robbert J Rottier; Pieter S Hiemstra; Aurélie Carlier; Clemens van Blitterswijk; Pamela Habibović; Stefan Giselbrecht; Roman Truckenmüller
Journal:  ACS Biomater Sci Eng       Date:  2022-05-03

7.  Study on biopharmaceutics classification and oral bioavailability of a novel multikinase inhibitor NCE for cancer therapy.

Authors:  Yang Yang; Chun-Mei Fan; Xuan He; Ke Ren; Jin-Kun Zhang; Ying-Ju He; Luo-Ting Yu; Ying-Lan Zhao; Chang-Yang Gong; Yu Zheng; Xiang-Rong Song; Jun Zeng
Journal:  Int J Mol Sci       Date:  2014-04-25       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.